How The US FDA Responded To Cipla’s Dismissal Of Rescue Inhaler Complaints

 
• By Bowman Cox

Could Cipla dissuade the FDA from issuing a warning letter by defending the dismissal of thousands of complaints from asthma sufferers about jammed albuterol inhalers that came to light during a site inspection? The agency’s answer came in a warning letter.

Rescue inhaler
rescue at hand, or not • Source: Shutterstock

More from Manufacturing

More from Compliance